Clinical Trial

EnVenomation Investigation Pilot to Evaluate Recovery

Study Description

SC2i VIPER: EnVenomation Investigation Pilot to Evaluate Recovery

The purpose of this study is to pilot data for a systematic molecular characterization of pathophysiologic perturbations incurred by snake envenomation and compare this to other inflammatory physiologic states such as trauma and sepsis. This sub-study will analyze samples of participants enrolled under the parent study "Surgical Critical Care Initiative Tissue and Data Acquisition Protocol".

Location

Locations Selected Location

Methods

No pharmaceutical medication involved No pharmaceutical medication involved
Patients and healthy individuals accepted Patients and healthy individuals accepted

Research interventions of blood sampling and data collection

Patient-Specific Functional Scale (PSFS) survey will be administered to patients to record symptoms at both the time of evaluation in the emergency department and in follow up by phone at 3, 7, 14, 21 and 28 days after discharge from the emergency department or hospital. The rest of the patients' care will be as usual care, and patients will have had research interventions of blood sampling and data collection as noted in the previously approved SC2i Tissue Data Acquisition Protocol (TDAP) Pro00 ...read more on ClinicalTrials.org

Additional Information

Official Study Title

SC2i VIPER: EnVenomation Investigation Pilot to Evaluate Recovery

Clinical Trial ID

NCT03170297

ParticipAid ID

wdLpwd